A Study of Trastuzumab Emtansine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Who Have Received Prior Anti-HER2 And Chemotherapy-based Treatment

Condition:   Breast Cancer
Intervention:   Drug: Trastuzumab Emtansine
Sponsor:   Hoffmann-La Roche
Recruiting - verified March 2017

http://ift.tt/2npWTpa